webinar
Oct. 27-28, 2025, Boston, MA, USA - Booth 114.
Read More

BCN-exo-PEG7-maleimide

  CAS No.: 2143965-47-1   Cat No.: BADC-01780 4.5  

BCN-exo-PEG7-maleimide is a bioorthogonal ADC linker featuring bicyclononyne and maleimide groups, optimized for rapid copper-free click conjugation and stable antibody-drug conjugate formation.

BCN-exo-PEG7-maleimide

Structure of 2143965-47-1

Quality
Assurance

Worldwide
Delivery

24/7 Customer
Support
Category
ADC Linker
Molecular Formula
C34H53N3O12
Molecular Weight
695.80

* For research and manufacturing use only. We do not sell to patients.

Size Price Stock Quantity
-- $-- In stock

Looking for different specifications? Click to request a custom quote!

Capabilities & Facilities

Popular Publications Citing BOC Sciences Products
Synonyms
5,8,11,14,17,20,23-Heptaoxa-2,26-diazanonacosanoic acid, 29-(2,5-dihydro-2,5-dioxo-1H-pyrrol-1-yl)-27-oxo-, (1R,8S)-bicyclo[6.1.0]non-4-yn-9-ylmethyl ester, rel-
IUPAC Name
9-bicyclo[6.1.0]non-4-ynylmethyl N-[2-[2-[2-[2-[2-[2-[2-[2-[3-(2,5-dioxopyrrol-1-yl)propanoylamino]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethyl]carbamate
Canonical SMILES
C1CC2C(C2COC(=O)NCCOCCOCCOCCOCCOCCOCCOCCNC(=O)CCN3C(=O)C=CC3=O)CCC#C1
InChI
InChI=1S/C34H53N3O12/c38-31(9-12-37-32(39)7-8-33(37)40)35-10-13-42-15-17-44-19-21-46-23-25-48-26-24-47-22-20-45-18-16-43-14-11-36-34(41)49-27-30-28-5-3-1-2-4-6-29(28)30/h7-8,28-30H,3-6,9-27H2,(H,35,38)(H,36,41)
InChIKey
KLGLXRNSORBLCE-UHFFFAOYSA-N
Density
1.23±0.1 g/cm3
Boiling Point
821.1±65.0 °C at 760 mmHg

BCN-exo-PEG7-maleimide is widely used in the field of bioconjugation, where it serves as a crosslinker between biomolecules. Its maleimide group specifically reacts with thiol groups, typically found in cysteine residues of proteins or peptides. This reaction forms a stable thioether bond, ensuring that the conjugation is robust and durable. The BCN (bicyclo[6.1.0]nonyne) group can bind to azide-functionalized molecules through strain-promoted alkyne-azide cycloaddition (SPAAC), a copper-free “click” chemistry reaction. This dual reactivity makes BCN-exo-PEG7-maleimide a valuable tool for attaching diverse biomolecules in a controlled and efficient manner.

Another crucial application of BCN-exo-PEG7-maleimide is in the development of drug delivery systems. By attaching therapeutic agents to nanoparticles or other delivery vehicles using this linker, the drugs can be more effectively targeted to specific tissues or cells. The PEG (polyethylene glycol) spacer enhances the solubility and biocompatibility of the conjugate, reducing potential immunogenicity and increasing circulation time in the body. This can lead to improved therapeutic outcomes and reduced side effects, as the drug is delivered more precisely to its intended site.

BCN-exo-PEG7-maleimide is also instrumental in the field of diagnostics. It can be used to conjugate imaging agents or probes to targeting molecules, such as antibodies or peptides, that specifically bind to biomarkers of diseases. For instance, in cancer diagnostics, this linker can help create conjugates that selectively accumulate in tumor cells, allowing for enhanced imaging clarity and early detection. The biocompatibility and specificity provided by BCN-exo-PEG7-maleimide conjugation are crucial for developing accurate and reliable diagnostic tools.

Lastly, BCN-exo-PEG7-maleimide finds significant usage in the creation of bioactive surfaces and materials. By modifying surfaces of polymers, hydrogels, or other materials with bioactive molecules using this linker, researchers can generate functionalized surfaces with specific biological activities. These modified surfaces can promote cell adhesion, growth, and differentiation, making them invaluable in tissue engineering and regenerative medicine. The ability to precisely control the presentation and density of bioactive molecules on surfaces facilitates the development of sophisticated biomaterials that can mimic natural tissue environments.

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Related Products

Contact our experts today for pricing and comprehensive details on our ADC offerings.

You May Also Be Interested In

From cytotoxin synthesis to linker design, discover our specialized services that complement your ADC projects.

ADC Linker Development Enzyme Cleavable Linker Cathepsin B Cleavable Linker/Peptide Linker Phosphatase Cleavable Linker β-Glucuronide Linker β-Galactosidase Cleavable Linker Sulfatase Cleavable Linker Chemically Cleavable Linker Non-Cleavable Linker Services Acid Cleavable Linker/Hydrazone Linker

Unlock Deeper ADC Insights

Learn more about payload design, linker strategies, and integrated CDMO support through our curated ADC content.

Linkers - A Crucial Factor in Antibody–Drug Conjugates In-Depth Review of ADC Linkers: Types, Mechanisms, and Research Progress New Structural Insights Solve Instability Issues of Maleimide Linkers in ADCs PEG Linkers in Antibody-Drug Conjugates Peptide Linkers in Antibody-Drug Conjugates Disulfide Linkers in Antibody-Drug Conjugates Biotinylation Reagents in Antibody-Drug Conjugates Maleimide Linkers in Antibody-Drug Conjugates Current ADC Linker Chemistry SPDB Linkers in Antibody-Drug Conjugates

Explore More ADC Products

Find exactly what your project needs from our expanded range of ADCs, offering flexible options to fit your timelines and goals.

ADC Cytotoxin

Powerful Targeted Cancer Solutions

ADC  Cytotoxin with Linker

Enhanced Stability And Efficacy

ADC Linker

Precise Conjugation For Success

Antibody-Drug  Conjugates (ADCs)

Maximized Therapeutic Performance

Auristatins

Next-Level Tubulin Inhibition

Calicheamicins

High-Impact DNA Targeting

Camptothecins

Advanced Topoisomerase Inhibition

Daunorubicins / Doxorubicins

Trusted Anthracycline Payloads

Duocarmycins

Potent DNA Alkylation Agents

Maytansinoids

Superior Microtubule Disruption

Pyrrolobenzodiazepines

Ultra-Potent DNA Crosslinkers

Traditional Cytotoxic Agents

Proven Chemotherapy Solutions

Cleavable Linker

Precise Intracellular Drug Release

Non-Cleavable Linker

Exceptional Long-Term Stability

Historical Records: Acetylene-linker-Val-Cit-PABC-MMAE | DBCO-PEG4-GGFG-DMEA-PNU159682 | DM1-SMCC | DM21 | MA-PEG4-VC-PAB-MMAE | Z-D-Dbu(N3)-OH | Ansamitocin P-3 | N-(Iodoacetamido)-Doxorubicin | Boc-(4R)-4-azido-D-proline | Bis-Propargyl-PEG18 | BCN-exo-PEG7-maleimide
Send Inquiry
Verification code
Inquiry Basket